141 related articles for article (PubMed ID: 1181667)
1. The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein, and fat.
Sakurai H; Dobbs RE; Unger RH
Diabetologia; 1975 Oct; 11(5):427-30. PubMed ID: 1181667
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenously administered glucose on glucagon and insulin secretion during fat absorption.
Dobbs R; Faloona GR; Unger RH
Metabolism; 1975 Jan; 24(1):69-75. PubMed ID: 1110626
[TBL] [Abstract][Full Text] [Related]
3. Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man.
Lucey MR; Fairclough PD; Wass JA; Kwasowski P; Medbak S; Webb J; Rees LH
Clin Endocrinol (Oxf); 1984 Sep; 21(3):209-17. PubMed ID: 6148162
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
Sakurai H; Dobbs R; Unger RH
J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
[TBL] [Abstract][Full Text] [Related]
5. The effect of calcium and other salts upon the release of glucagon-like immunoreactivity from the gut.
Böttger I; Faloona GR; Unger RH
J Clin Invest; 1972 Apr; 51(4):831-6. PubMed ID: 5014613
[TBL] [Abstract][Full Text] [Related]
6. Rate dependent stimulation of insulin and glucagon but not gastrin and somatostatin release during the intestinal phase of a meal.
Schusdziarra V; Dangel G; Henrichs I; Klier M; Pfeiffer EF
Horm Metab Res; 1982 Apr; 14(4):169-71. PubMed ID: 6123480
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
[TBL] [Abstract][Full Text] [Related]
8. Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations.
Boden G; Essa N; Owen OE; Reichle FA
J Clin Invest; 1974 Apr; 53(4):1185-93. PubMed ID: 4815082
[TBL] [Abstract][Full Text] [Related]
9. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
[TBL] [Abstract][Full Text] [Related]
10. Correlation of endogenous somatostatin, gastric inhibitory polypeptide, glucagon and insulin with gastric function in the conscious calf.
Bell FR; Webber DE; Wass JA; Rees LH; Evans J; Morgan LM; Marks V; Lewis J
J Endocrinol; 1981 Jun; 89(3):451-6. PubMed ID: 6114125
[TBL] [Abstract][Full Text] [Related]
11. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
[TBL] [Abstract][Full Text] [Related]
12. The effects of triglyceride absorption upon glucagon, insulin, and gut glucagon-like immunoreactivity.
Böttger I; Dobbs R; Faloona GR; Unger RH
J Clin Invest; 1973 Oct; 52(10):2532-41. PubMed ID: 4738064
[TBL] [Abstract][Full Text] [Related]
13. Failure of somatostatin to decrease blood glucose by suppression of extrapancreatic glucagon in severely diabetic depancreatized dogs.
Matsuyama T; Tanaka R; Shima K; Tarui S
Endocrinol Jpn; 1978 Dec; 25(6):529-32. PubMed ID: 751798
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy males.
Wu T; Rayner CK; Watson LE; Jones KL; Horowitz M; Little TJ
Peptides; 2017 Sep; 95():124-127. PubMed ID: 28800948
[TBL] [Abstract][Full Text] [Related]
15. Effect of somatostatin on determinants of bile flow in unanesthetized dogs.
Lewis MH; Baker AL; Ipp E; Moossa AR
Ann Surg; 1982 Jan; 195(1):97-103. PubMed ID: 6119961
[TBL] [Abstract][Full Text] [Related]
16. Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: A randomised controlled trial.
Thazhath SS; Wu T; Bound MJ; Checklin HL; Standfield S; Jones KL; Horowitz M; Rayner CK
Nutrition; 2016 May; 32(5):553-9. PubMed ID: 26792024
[TBL] [Abstract][Full Text] [Related]
17. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
Lien E; Sarantakis D
Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
[TBL] [Abstract][Full Text] [Related]
18. Effects of acutely infused pentagastrin and somatostatin on intestinal calcium absorption in humans.
Scholz D; Schwille PO
Miner Electrolyte Metab; 1982 Feb; 7(2):76-85. PubMed ID: 6133213
[TBL] [Abstract][Full Text] [Related]
19. Portal venous hyperinsulinemia does not stimulate gut glucose absorption in the conscious dog.
Camacho RC; Denny JC; Pencek RR; Koyama Y; Lacy DB; James FD; Wasserman DH
Metabolism; 2004 Oct; 53(10):1290-5. PubMed ID: 15375784
[TBL] [Abstract][Full Text] [Related]
20. Effect of somatostatin on duodenal glucose absorption in man.
Féry F; Tappy L; Schneiter P; Devière J; Balasse EO
J Clin Endocrinol Metab; 2005 Jul; 90(7):4163-9. PubMed ID: 15827105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
